BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2455597)

  • 1. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J; Oehr P; Maisey R; Adolphs HD
    Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G; Wechsel HW; Nelde HJ; Bichler KH
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
    Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
    Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
    Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
    Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
    Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
    Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
    Moreno Sierra J; Ortega MD; Blanco Jimenez E; Maestro de las Casas ML; Delgado Marti JA; Hermida Gutierrez J; Salinas Casado J; Esteban Fuertes M; Resel Estévez L
    Arch Esp Urol; 1994; 47(1):39-42. PubMed ID: 8192496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CEA and TPA in bladder carcinoma].
    Latella G; Ciarniello P; Fusco A; Liberti M; Gentile V; De Berardinis E; Von Heland M
    Minerva Med; 1986 Mar; 77(13):505-6. PubMed ID: 3703342
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M; Schlegel G
    Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in cytological specimens of urothelial carcinoma.
    Holmberg V; Wahren B; Esposti PL
    Cytometry; 1984 Jul; 5(4):437-41. PubMed ID: 6380996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms].
    Krajewska B; Stelmach W; Lutz W; Matych J
    Med Pr; 1995; 46(1):7-16. PubMed ID: 9732842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid].
    Loos U; Oehr P; Genske F; Schlack W
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():235-7. PubMed ID: 3174571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.